Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hygeia Healthcare Holdings Co., Ltd. is the largest private oncology healthcare group in China, specializing in the operation of oncology-focused hospitals and the provision of radiotherapy center services. The company addresses the significant undersupply of oncology services in China by offering a comprehensive suite of treatments, including radiotherapy, surgery, chemotherapy, and targeted therapy. Hygeia's business model integrates hospital management with the proprietary manufacture and sale of radiotherapy equipment, positioning it as a dominant player in the Chinese oncology market. With a strategic focus on tier-two and tier-three cities, the company continues to expand its network through both organic growth and the strategic acquisition of existing hospitals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hygia Healthcare.